Prophylactic antibiotics in labor and delivery

Obstetrics and Gynecology

Volumn 102, Issue 4, 2003, Pages 875-882

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALOTIN; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PENICILLIN G; PIPERACILLIN; VANCOMYCIN;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL TRIAL; DELIVERY; DRUG COST; DRUG DISTRIBUTION; DRUG HALF LIFE; ENDOMETRITIS; ENTEROCOCCUS; ESCHERICHIA COLI; EXFOLIATIVE DERMATITIS; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION; LABOR; MEMBRANE RUPTURE; NEWBORN SEPSIS; PENICILLIN RESISTANCE; PLACENTA; PREMATURE FETUS MEMBRANE RUPTURE; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; PUERPERIUM; RASH; REVIEW; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; URTICARIA; UTERINE CERVIX CERCLAGE; WOUND INFECTION; ARTICLE; FEMALE; HIGH RISK PREGNANCY; LABOR COMPLICATION; PRACTICE GUIDELINE; PREGNANCY; PUERPERAL INFECTION;

ANTIBIOTIC PROPHYLAXIS; ENDOCARDITIS, BACTERIAL; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY, HIGH-RISK; PUERPERAL INFECTION;

EID: 0142228158     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00984-0     Document Type: Short Survey

References (59)

1. Kaiser AB. Antimicrobial prophylaxis in surgery. N Engl J Med 1986;315:1129-38. (Level III)
2. Archer GL. Alteration of cutaneous staphylococcal flora as a consequence of antimicrobial prophylaxis. Rev Infect Dis 1991;13:S805-9. (Level III)
3. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7. (Level II-2)
4. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenler case-control study. Pediatrics 2000;105:21-6. (Level II-2)
5. Towers CV, Cart MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-83. (Level III)
6. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3. (Level II-2)
7. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8. (Level III)
8. Stiver HG, Forward KR, Tyrrell DL, Krip G, Livingstone RA, Fugere P, et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. Am J Obstet Gynecol 1984;149:718-21. (Level I)
9. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 1999;180:1345-8. (Level III)
10. Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol 2002;187:495-500. (Level II-2)
11. Friedman S, Shah V, Ohlsson A, Matlow AG. Neonatal escherichia coil infections: concerns regarding resistance to current therapy. Acta Paediat 2000;89:686-9. (Level III)
12. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22. (Level III)
13. Bland ML, Vermillion ST, Soper DE, Austin M. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol 2001;184:1125-6. (Level II-3)
14. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-61. (Level II-3)
15. Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53. (Level III)
16. Report of the ASM task force of antibiotic resistance. Antimicrob Agents Chemother 1995;(suppl):1-23. (Level III)
17. Moellering RC Jr. Principles of anti-infective therapy. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Vol 1. 5th ed. Philadelphia (PA): Churchill Livingstone: 2000. p. 223-35. (Level III)
18. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001;345:804-9. (Level III)
19. Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;181:103-4. (Level II-3)
20. Dunn AB, Blomquist J, Khouzami V. Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. J Reprod Med 1999;44:381-4. (Level III)
21. Sweet RL, Gibbs RS. Antimicrobial agents. In: Infectious diseases of the female genital tract. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2002. p. 609-60. (Level III)
22. Heikkila A, Renkonen OV, Erkkola R. Pharmacokinetics and transplacental passage of imipenem during pregnancy. Antimicrob Agents Chemother 1992;36:2652-5. (Level III)
23. Fiore Mitchell T, Pearlman MD, Chapman RL. Bhatt-Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001;98:1075-9. (Level II-3)
24. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000;107:770-5. (Level III)
25. Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. N Engl J Med 1973;288:1219-21. (Level II-1)
26. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91:112-4. (Level III)
27. Harger JH. Cerclage and cervical insufficiency: an evidence-based analysis [published erratum appears in Obstet Gynecol 2003;101:205]. Obstet Gynecol 2002;100:1313-27. (Level III)
28. Charles D, Edwards WR. Infectious complications of cervical cerclage. Am J Obstet Gynecol 1981;141:1065-71. (Level II-3)
29. Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Ant J Obstet Gynecol 1992;167:1086-91. (Level II-3)
30. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis for cesarean section (Cochrane Review). In: The Cochrane Library. Issue 2, 2003. Oxford: Update Software. (Level I)
31. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990;75:52-8. (Level II-2)
32. Gibbs RS, St Clair PJ, Castillo MS, Castaneda YS. Bacteriologic effects of antibiotic prophylaxis in high-risk cesarean section. Obstet Gynecol 1981;57:277-82. (Level I)
33. Bagratee JS, Moodley J, Kleinschmidt I, Zawilski W. A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery. BJOG 2001;108:143-8. (Level I)
34. Duff P, Smith PN, Keiser JF. Antibiotic prophylaxis in low risk cesarean section. J Reprod Med 1982;27:133-8. (Level II-2)
35. Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gynecol 2001;184:656-61. (Level III)
36. Currier JS, Tosteson TD, Platt R. Cefazolin compared with cefoxitin for cesarean section prophylaxis: the use of a two-stage study design. J Clin Epidemiol 1993;46:625-30. (Level II-2)
37. Carlson C, Duff P. Antibiotic prophylaxis for cesarean delivery: is an extended-spectrum agent necessary? Obstet Gynecol 1990;76:343-6. (Level I)
38. Faro S, Martens MG, Hammill HA, Riddle G, Tortolero G. Antibiotic prophylaxis: is there a difference? Am J Obstet Gynecol 1990;162:900-7: discussion 907-9. (Level I)
39. Hopkins L, Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software. (Level I)
40. Gonik B. Single- versus three-dose cefotaxime prophylaxis for cesarean section. Obstet Gynecol 1985;65:189-93. (Level I)
41. Roex AJ, Puyenbroek JI, van Loenen AC, Arts NF. Singleversus three-dose cefoxitin prophylaxis in caesarean section: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 1987;25:293-8. (Level I)
42. Saltzman DH, Eron LJ, Tuomala RE, Protomastro LJ, Sites JG. Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section. A comparative trial. J Reprod Med 1986;31:709-12. (Level I)
43. Christmas JT, Cox SM, Andrews W, Dax J, Leveno KJ, Gilstrap LC. Expectant management of preterm ruptured membranes: effects of antimicrobial therapy. Obstet Gynecol 1992;80:759-62. (Level I)
44. Ernest JM, Givner LB. A prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes. Am J Obstet Gynecol 1994;170:516-21. (Level I)
45. Kenyon S, Boulvain M, Nelson J. Antibiotics for preterm rupture of membranes (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software. (Level I)
46. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-95. (Level I)
47. Mercer BM, Moretti ML, Prevost RR, Sibai BM. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol 1992;166:794-802. (Level I)
48. Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Obstet Gynecol 1993;169:976-81. (Level I)
49. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-95. (Level I)
50. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes [published erratum appears in: Lancet 1996;347:410]. Lancet 1995;346:1271-9. (Meta-analysis)
51. Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A, et al. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a meta-analysis. Am J Obstet Gynecol 1996;174:589-97. (Meta-analysis)
52. Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of the fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group [published erratum appears in: Lancet 2001;358:156]. Lancet 2000;357:979-88. (Level I)
53. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38-44. (Level III)
54. Sugrue D. Blake S, Troy P, MacDonald D. Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 1980;44:499-502. (Level III)
55. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease. Circulation 1998;98:1949-84. (Level III)
56. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801. (Level III)
57. Atkinson MW, Owen J, Wren A, Hauth JC. The effect of manual removal of the placenta on post-cesarean endometritis. Obstet Gynecol 1996;87:99-102. (Level I)
58. Lasley DS, Eblen A, Yancey MK, Duff P. The effect of placental removal method on the incidence of postcesarean infections. Am J Obstet Gynecol 1997;176:1250-4. (Level I)
59. Magann EF, Washburne JF, Harris RL, Bass JD, Duff WP, Morrison JC. Infectious morbidity, operative blood loss, and length of the operative procedure after cesarean delivery by method of placental removal and site of uterine repair. J Am Coll Surg 1995;181:517-20. (Level I)